These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9585908)

  • 21. [A patient with recurrent gastric cancer who developed TS-1 induced hand-foot syndrome].
    Arai K; Iwasaki Y; Kimura Y; Takahashi K; Yamaguchi T; Honma S; Takahashi T
    Gan To Kagaku Ryoho; 2003 May; 30(5):699-702. PubMed ID: 12795105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. S-1 induces meibomian gland dysfunction.
    Matsumoto Y; Dogru M; Sato EA; Ibrahim OM; Tatematsu Y; Ogawa Y; Tsubota K
    Ophthalmology; 2010 Jun; 117(6):1275.e4-7. PubMed ID: 20522337
    [No Abstract]   [Full Text] [Related]  

  • 23. Myelodysplastic syndrome/acute myelogenous leukaemia related to adjuvant chemotherapy with oral pyrimidine anti-metabolites.
    Abe M; Tanaka Y; Shinohara M; Kosaka M; Matsumoto T
    Br J Haematol; 2000 Nov; 111(2):712-3. PubMed ID: 11122127
    [No Abstract]   [Full Text] [Related]  

  • 24. Palmoplantar keratoderma: an adverse reaction to influenza vaccination.
    Lim D; Rademaker M; Gardner D; Oakley A
    Australas J Dermatol; 2011 Nov; 52(4):298-300. PubMed ID: 22070708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Olmutinib-induced palmoplantar keratoderma.
    Chen KL; Cho YT; Yang CW; Sheen YS; Liang CW; Lacouture ME; Chu CY
    Br J Dermatol; 2018 Feb; 178(2):e129-e131. PubMed ID: 28869782
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
    Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary toxicity by an oral anti-neoplatic agent, S-1.
    Ohara G; Satoh H; Hizawa N
    Intern Med; 2008; 47(3):187; author reply 189. PubMed ID: 18239333
    [No Abstract]   [Full Text] [Related]  

  • 28. Discoid lupus erythematosus (DLE)-like lesion induced by uracil-tegafur (UFT).
    Yoshimasu T; Hiroi A; Uede K; Furukawa F
    Eur J Dermatol; 2001; 11(1):54-7. PubMed ID: 11174141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Corneal epithelial disorder, lacrimal drainage obstruction, and conjunctivitis].
    Kase S
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():490-3. PubMed ID: 25831809
    [No Abstract]   [Full Text] [Related]  

  • 30. Acral lentiginosis associated with tegafur/gimeracil/oteracil (TS-1).
    Park YJ; Soh BW; Lee ES
    Eur J Dermatol; 2017 Apr; 27(2):209-210. PubMed ID: 28251899
    [No Abstract]   [Full Text] [Related]  

  • 31. Tepotinib-Induced Palmoplantar Keratoderma-Like Hand-Foot Skin Reaction.
    Chen CH; Hsu CK; Lee CN
    J Thorac Oncol; 2023 Apr; 18(4):e33-e34. PubMed ID: 36990574
    [No Abstract]   [Full Text] [Related]  

  • 32. Raynaud's phenomenon possibly induced by a compund drug of tegafur and uracil.
    Seishima M; Izumi T; Kanoh H
    Eur J Dermatol; 2000; 10(1):55-8. PubMed ID: 10694301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of knuckle-pad-like changes in ceratoma palmare et plantare].
    TRINKAUS T
    Dermatol Wochenschr; 1952; 126(37):879-83. PubMed ID: 12979631
    [No Abstract]   [Full Text] [Related]  

  • 34. Myotonia and keratoderma induced by 20,25 diazacholestenol.
    Anderson PC; Martt JM
    Arch Dermatol; 1965 Aug; 92(2):181-3. PubMed ID: 11850925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic liver failure induced by long-term administration of tegafur: a case report.
    Matsumoto M; Nakao K; Matsumoto H; Iwata K; Ohta Y; Kanai K; Takahashi K; Akima M
    Hepatogastroenterology; 1998; 45(24):2372-5. PubMed ID: 9951926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A Case of Recurrent Gallbladder Cancer with a Complete Response to S-1 Alternate-Day Administration].
    Eto R; Nakatsu H; Ozasa H; Shimizu R
    Gan To Kagaku Ryoho; 2016 Jan; 43(1):111-3. PubMed ID: 26809537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Biochemical modulation by leucovorin of the antineoplastic effect of fluorofur in disseminated colorectal cancer].
    Manziuk LV; Perevodchikova NI; Gorbunova VA; Luk'ianchenko AB; Abramova NA
    Vopr Onkol; 1996; 42(3):33-6. PubMed ID: 8801738
    [No Abstract]   [Full Text] [Related]  

  • 38. Chronic active hepatitis and liver cirrhosis in association with combined tamoxifen/tegafur adjuvant therapy.
    Maruyama S; Hirayama C; Abe J; Tanaka J; Matsui K
    Dig Dis Sci; 1995 Dec; 40(12):2602-7. PubMed ID: 8536519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Clinical Evaluation of Tegafur Gimeracil Oteracil Combined with THP and DDP for Second-Line Treatment of Advanced Cardiac Carcinoma.
    Wang HF; Lv JQ
    Cell Biochem Biophys; 2015 Jul; 72(3):695-9. PubMed ID: 25618173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary toxicity by a cytotoxic agent, S-1.
    Tada Y; Takiguchi Y; Fujikawa A; Kitamura A; Kurosu K; Hiroshima K; Sakao S; Kasahara Y; Tanabe N; Tatsumi K; Kuriyama T
    Intern Med; 2007; 46(15):1243-6. PubMed ID: 17675777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.